Browse by People

Collapse authors list.
Lin, Wei-Yu, Fordham, Sarah E, Sunter, Nicola, Elstob, Claire, Rahman, Thahira, Willmore, Elaine, Shepherd, Colin, Strathdee, Gordon, Mainou-Fowler, Tryfonia, Piddock, Rachel et al (show 26 more authors) , Mearns, Hannah, Barrow, Timothy, Houlston, Richard S, Marr, Helen, Wallis, Jonathan, Summerfield, Geoffrey, Marshall, Scott, Pettitt, Andrew, Pepper, Christopher, Fegan, Christopher, Forconi, Francesco, Dyer, Martin JS, Jayne, Sandrine, Sellors, April, Schuh, Anna, Robbe, Pauline, Oscier, David, Bailey, James, Rais, Syed, Bentley, Alison, Cawkwell, Lynn, Evans, Paul, Hillmen, Peter, Pratt, Guy, Allsup, David J and Allan, James M (2021) Genome-wide association study identifies risk loci for progressive chronic lymphocytic leukemia. NATURE COMMUNICATIONS, 12 (1). 665-.

Hill-McManus, Daniel, Soto, Elena, Marshall, Scott, Lane, Steven and Hughes, Dyfrig ORCID: 0000-0001-8247-7459 (2018) Impact of non-adherence on the safety and efficacy of uric acid-lowering therapies in the treatment of gout. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 84 (1). pp. 142-152.

Collapse authors list.
Pettitt, Andrew R, Jackson, Richard, Cicconi, Silvia ORCID: 0000-0001-5507-6203, Polydoros, Fotis, Yap, Christina, Dodd, James, Bickerstaff, Matthew, Stackpoole, Michael, Khan, Umair T ORCID: 0000-0002-9470-3481, Carruthers, Stacey et al (show 16 more authors) , Oates, Melanie, Lin, Ke, Coupland, Sarah E ORCID: 0000-0002-1464-2069, Menon, Geetha, Kalakonda, Nagesh ORCID: 0000-0002-5300-1360, McCarthy, Helen, Bloor, Adrian, Schuh, Anna, Duncombe, Andrew, Dearden, Claire, Fegan, Christopher, Kennedy, Ben, Walewska, Renata, Marshall, Scott, Fox, Christopher P and Hillmen, Peter (2020) Lenalidomide, dexamethasone and alemtuzumab or ofatumumab in high-risk chronic lymphocytic leukemia: final results of the NCRI CLL210 trial. HAEMATOLOGICA, 105 (12). pp. 2868-2871.

Hill-McManus, Daniel, Marshall, Scott, Liu, Jing, Willke, Richard J and Hughes, Dyfrig A ORCID: 0000-0001-8247-7459 (2021) Linked Pharmacometric-Pharmacoeconomic Modeling and Simulation in Clinical Drug Development. CLINICAL PHARMACOLOGY & THERAPEUTICS, 110 (1). pp. 49-63.

Collapse authors list.
Milojkovic, Dragana, Cross, Nicholas CP, Ali, Sahra, Byrne, Jenny, Campbell, Gavin, Dignan, Fiona L, Drummond, Mark, Huntly, Brian, Marshall, Scott, McMullin, Mary Frances et al (show 12 more authors) , Neelakantan, Pratap, Raghavan, Manoj, Sivakumaran, Muttuswamy, Tighe, Jane, Wandroo, Farooq, Willis, Fenella, Glen, Fiona, Fildes, Louise, Collington, Sarah J, Ryan, Jacqueline, Clark, Richard E ORCID: 0000-0002-1261-3299 and Mead, Adam J (2021) Real-world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UK TARGET CML study. BRITISH JOURNAL OF HAEMATOLOGY, 192 (1). pp. 62-74.